BP
NVO

BBR Partners’s Novo Nordisk NVO Stock Holding History

BBR Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,798
Closed -$214K – 267
2024
Q3 		$214K Hold
1,798
– – 0.02% 218
2024
Q2 		$257K Sell
1,798
-405
-18% -$53.7K 0.02% 178
2024
Q1 		$283K Hold
2,203
– – 0.02% 199
2023
Q4 		$228K Buy
+2,203
New +$218K 0.02% 163
2020
Q1 		– Sell
-20,258
Closed -$586K – 188
2019
Q4 		$586K Buy
+20,258
New +$561K 0.06% 102

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BBR Partners's NVO Position: Q4 2024 in Review

BBR Partners sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,798 shares — an estimated $214K sold.

BBR Partners first reported a position in NVO in Q4 2019 and held it in 5 quarters. The position peaked at $586K in Q4 2019. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • BBR Partners reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • BBR Partners sold 1,798 Novo Nordisk shares in Q4 2024, an estimated $214K.
  • BBR Partners first reported a position in Novo Nordisk in Q4 2019 and held it in 5 quarters.
  • BBR Partners's Novo Nordisk position peaked at $586K in Q4 2019.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on BBR Partners's 13F filing for Q4 2024, filed 7 Feb 2025.